跳至主要内容
临床试验/NCT01008683
NCT01008683Unknown不适用

Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart Transplantation

Hadassah Medical Organization1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2009年11月最近更新:
适应症

试验速览

阶段
不适用
入组人数
300
试验地点
1

研究概览

简要总结

Stem cell and and heart transplant patients will receive pandemic H1N1 influenza vaccination according to the clinical guidelines.

In these patients the investigators will measure the specific antibody production.

详细描述

Stem cell and and heart transplant patients will receive pandemic H1N1 influenza vaccination according to the clinical guidelines. Two doses will be given, in 3-week interval.

In these patients we will measure the specific antibody production. Blood sample 5 ml will be drawn before the first vaccine, before the second, and 3-4 weeks after the 2nd dose.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
— 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Stem cell and and heart transplant patients who will receive pandemic H1N1 influenza vaccination according to the clinical guidelines.

排除标准

  • Patients with unstable grafts.

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Antibody Production Following H1N1 Influenza... | 临床试验